Home
>
National Drug Code (NDC)
>
SPRYCEL
SPRYCEL - 0003-0857-22 - (dasatinib)
Drug Information of SPRYCEL
| Product NDC: | 0003-0857 |
| Proprietary Name: | SPRYCEL |
| Non Proprietary Name: | dasatinib |
| Active Ingredient(s): | 140 mg/1 & nbsp; dasatinib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SPRYCEL
| Product NDC: | 0003-0857 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021986 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101028 |
Package Information of SPRYCEL
| Package NDC: | 0003-0857-22 |
| Package Description: | 1 BOTTLE in 1 CARTON (0003-0857-22) > 30 TABLET in 1 BOTTLE |
NDC Information of SPRYCEL
| NDC Code | 0003-0857-22 |
| Proprietary Name | SPRYCEL |
| Package Description | 1 BOTTLE in 1 CARTON (0003-0857-22) > 30 TABLET in 1 BOTTLE |
| Product NDC | 0003-0857 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dasatinib |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101028 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | DASATINIB |
| Strength Number | 140 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
